Stock listing
NASDAQ:SGEN Seagen Inc Stock
Follow Seagen Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SGEN
$228.74 USD
Close on Dec 13, 2023 · No longer trades
- Lowest – highest close
- $2.25 – $228.90 USDSince Mar 7, 2001 · lowest Apr 11, 2003 · highest Dec 12, 2023
Delisted NASDAQ:SGEN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SGEN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Seagen Inc on 6ix
- Calls
- 9 calls with a replay · 9 with a transcript · latest Feb 15, 2023
- Decks
- 1 deck · latest Mar 13, 2023
Events
| Call | When | Status |
|---|---|---|
| Seagen (SGEN) Q4 2022 Earnings Call | Wed, Feb 15, 2023 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2022 Earnings Call | Thu, Oct 27, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2022 Earnings Call | Thu, Jul 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2022 Earnings Call | Thu, Apr 28, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2021 Earnings Call | Wed, Feb 09, 2022 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q3 2021 Earnings Call | Thu, Oct 28, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q1 2021 Earnings Call | Thu, Apr 29, 2021 · 4:30 PM ET | Replay |
| Seagen (SGEN) Q4 2020 Earnings Call | Thu, Feb 11, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2023) | Merger or acquisition | 20 slides | Mar 13, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alpna Seth Other companies: Keros Therapeutics, Inc. (Director · Since at least May 1, 2023); Bio-Techne Corp (Director · Since at least Oct 26, 2017) | Director · Mar 15, 2018 – Dec 14, 2023 · Past |
| David R. Epstein Other companies: AgomAb Therapeutics NV (Director · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024) | CEO, Director · Nov 10, 2023 – Dec 14, 2023 · Past |
| Jean Liu Other companies: Connect Biopharma Holdings Limited (Board Director · Since at least Mar 16, 2026); Erasca, Inc. (Director · Since at least Jan 1, 2024) | Chief Legal Officer · Dec 14, 2023 – Dec 14, 2023 · Past |
| Todd Simpson Other companies: Xencor, Inc. (Director · Since at least Mar 13, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past) | Chief Financial Officer · Apr 20, 2022 – Dec 14, 2023 · Past |
| Marc E. Lippman Other companies: Ascentage Pharma Group International (Independent non-executive Director · Since at least Mar 18, 2026) | Director · May 20, 2019 – May 14, 2021 · Past |
| Morris Rosenberg Other companies: Immunomedics Inc (Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past) | EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past |
Log in to ask 6ix AI your own questions about Seagen Inc.